@article{4b521430ab0346429ec8fbdb8a70ae68,
title = "Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer",
abstract = "High-grade serous ovarian cancer (HGSC) patients with no gross residual disease (R0) after primary surgery have the greatest improvement in clinical outcomes. A deep understanding of molecular and cellular heterogeneity of HGSC is lacking. Findings by Lee et al. highlight major molecular and cellular differences between clinically defined subgroups of HGSC.",
keywords = "R0 resection, copy number, genomics, immune monitoring, multi-omics, mutation, neoadjuvant chemotherapy, ovarian cancer, proteome, transcriptome",
author = "Sanghoon Lee and Li Zhao and Christine Rojas and Bateman, {Nicholas W.} and Hui Yao and Lara, {Olivia D.} and Joseph Celestino and Morgan, {Margaret B.} and Nguyen, {Tri V.} and Conrads, {Kelly A.} and Rangel, {Kelly M.} and Dood, {Robert L.} and Hajek, {Richard A.} and Fawcett, {Gloria L.} and Chu, {Randy A.} and Katlin Wilson and Loffredo, {Jeremy L.} and Coralie Viollet and Jazaeri, {Amir A.} and Dalgard, {Clifton L.} and Xizeng Mao and Xingzhi Song and Ming Zhou and Hood, {Brian L.} and Nirad Banskota and Wilkerson, {Matthew D.} and Jerez Te and Soltis, {Anthony R.} and Kristin Roman and Andrew Dunn and David Cordover and Eterovic, {Agda Karina} and Jinsong Liu and Burks, {Jared K.} and Baggerly, {Keith A.} and Fleming, {Nicole D.} and Lu, {Karen H.} and Westin, {Shannon N.} and Coleman, {Robert L.} and Mills, {Gordon B.} and Yovanni Casablanca and Jianhua Zhang and Conrads, {Thomas P.} and Maxwell, {George L.} and Futreal, {P. Andrew} and Sood, {Anil K.}",
note = "Publisher Copyright: {\textcopyright} 2020 The Author(s)",
year = "2020",
month = apr,
day = "14",
doi = "10.1016/j.celrep.2020.03.066",
language = "English",
volume = "31",
journal = "Cell Reports",
issn = "2211-1247",
number = "2",
}